| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |